We’ve been looking into healthcare companies to find a name that may be undervalued with solid growth prospects. Today’s company is one such name.
The company has a solid portfolio of FDA-approved drugs with the potential to expand usage. Furthermore, the company is now engaged in new and exciting innovative biotech initiatives.
